You have 10 free articles left this month. Get your freeBasic subscription now and gain instant access to more.

Bulgaria's Huvepharma signs 4.5 mln euro deal to deliver vaccines

Author Mario Tanev
Bulgaria's Huvepharma signs 4.5 mln euro deal to deliver vaccines Huvepharma/All rights reserved.

SOFIA (Bulgaria), July 12 (SeeNews) - Bulgaria's Food Safety Agency said on Friday that it has signed an 8.8 million levs ($5.1 million/4.5 million euro) contract with local drug maker Huvepharma, which will supply the agency with vaccines for nodular dermatitis.

Under the terms of the contract, Huvepharma will deliver 835,000 vaccines, the Food Safety Agency said in a notice.

The contract was signed on June 18.

Huvepharma filed the only bid in the public procurement procedure for awarding the contract.

The company develops both human and animal health products. It also manufactures and markets enzymes for food, feed and industrial applications.

Huvepharma's manufacturing subsidiary - Biovet, is headquartered in Peshtera, Bulgaria and has three production units in the country and two facilities in the USA. Huvepharma has representative offices and subsidiaries in Bulgaria, Belgium, Poland, China, Taiwan, Thailand, USA, Russia, India, Brazil and Turkey.

(1 euro = 1.95583 levs)

Compare